APO Research
Talk to an analyst

APO RESEARCH · REPORT

Efavirenz Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Efavirenz Tablets Industry Growth and Trends Forecast to 2032

23 December 202598 pages

Choose your research edition.

Industry ResearchEfavirenz Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Efavirenz Tablets Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Efavirenz Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Efavirenz Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Efavirenz Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Efavirenz Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Efavirenz Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Efavirenz Tablets include Aurobindo Pharma, Cipla, Hetero, Strides Pharma, Anhui Biochem Bio-Pharmaceutical, Huahai Pharmaceutical and DESANO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Efavirenz Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Efavirenz Tablets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Efavirenz Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Efavirenz Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Efavirenz Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Efavirenz Tablets Market by Company

Aurobindo Pharma

Cipla

Hetero

Strides Pharma

Anhui Biochem Bio-Pharmaceutical

Huahai Pharmaceutical

DESANO

Efavirenz Tablets Segment by Type

200mg

50mg

600mg

Efavirenz Tablets Segment by Application

Adult

Child

Efavirenz Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Efavirenz Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Efavirenz Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Efavirenz Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200mg Table 2. Major Company of 50mg Table 3. Major Company of 600mg Table 4. Global Efavirenz Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 6. Global Efavirenz Tablets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Efavirenz Tablets Sales Market Share in Value by Type (2021-2026) Table 9. Global Efavirenz Tablets Price by Type (2021-2026) & (USD/unit) Table 10. Global Efavirenz Tablets Sales by Type (2027-2032) & (k units) Table 11. Global Efavirenz Tablets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Efavirenz Tablets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Efavirenz Tablets Sales Market Share in Value by Type (2027-2032) Table 14. Global Efavirenz Tablets Price by Type (2027-2032) & (USD/unit) Table 15. North America Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 16. North America Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 18. Europe Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 22. Latin America Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Efavirenz Tablets Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Efavirenz Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Efavirenz Tablets Industry Trends Table 26. Efavirenz Tablets Industry Drivers Table 27. Efavirenz Tablets Industry Opportunities and Challenges Table 28. Efavirenz Tablets Industry Restraints Table 29. Global Efavirenz Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Efavirenz Tablets Revenue Market Share by Company (2021-2026) Table 31. Global Efavirenz Tablets Sales by Company (2021-2026) & (k units) Table 32. Global Efavirenz Tablets Sales Share by Company (2021-2026) Table 33. Global Efavirenz Tablets Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Efavirenz Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Efavirenz Tablets Major Company Production Sites and Headquarters Table 36. Global Efavirenz Tablets Company, Product Type & Application Table 37. Global Efavirenz Tablets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Efavirenz Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Efavirenz Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Efavirenz Tablets Sales by Region (2021-2026) & (k units) Table 42. Global Efavirenz Tablets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Efavirenz Tablets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Efavirenz Tablets Sales Market Share in Value by Region (2021-2026) Table 45. Global Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Efavirenz Tablets Sales by Region (2027-2032) & (k units) Table 47. Global Efavirenz Tablets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Efavirenz Tablets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Efavirenz Tablets Sales Market Share in Value by Region (2027-2032) Table 50. Global Efavirenz Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Efavirenz Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 53. Global Efavirenz Tablets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Efavirenz Tablets Sales Market Share in Value by Application (2021-2026) Table 56. Global Efavirenz Tablets Price by Application (2021-2026) & (USD/unit) Table 57. Global Efavirenz Tablets Sales by Application (2027-2032) & (k units) Table 58. Global Efavirenz Tablets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Efavirenz Tablets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Efavirenz Tablets Sales Market Share in Value by Application (2027-2032) Table 61. Global Efavirenz Tablets Price by Application (2027-2032) & (USD/unit) Table 62. North America Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 63. North America Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 65. Europe Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 69. Latin America Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Efavirenz Tablets Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Efavirenz Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. Aurobindo Pharma Company Information Table 73. Aurobindo Pharma Business Overview Table 74. Aurobindo Pharma Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Aurobindo Pharma Efavirenz Tablets Product Portfolio Table 76. Aurobindo Pharma Recent Development Table 77. Cipla Company Information Table 78. Cipla Business Overview Table 79. Cipla Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Cipla Efavirenz Tablets Product Portfolio Table 81. Cipla Recent Development Table 82. Hetero Company Information Table 83. Hetero Business Overview Table 84. Hetero Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Hetero Efavirenz Tablets Product Portfolio Table 86. Hetero Recent Development Table 87. Strides Pharma Company Information Table 88. Strides Pharma Business Overview Table 89. Strides Pharma Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Strides Pharma Efavirenz Tablets Product Portfolio Table 91. Strides Pharma Recent Development Table 92. Anhui Biochem Bio-Pharmaceutical Company Information Table 93. Anhui Biochem Bio-Pharmaceutical Business Overview Table 94. Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio Table 96. Anhui Biochem Bio-Pharmaceutical Recent Development Table 97. Huahai Pharmaceutical Company Information Table 98. Huahai Pharmaceutical Business Overview Table 99. Huahai Pharmaceutical Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Huahai Pharmaceutical Efavirenz Tablets Product Portfolio Table 101. Huahai Pharmaceutical Recent Development Table 102. DESANO Company Information Table 103. DESANO Business Overview Table 104. DESANO Efavirenz Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. DESANO Efavirenz Tablets Product Portfolio Table 106. DESANO Recent Development Table 107. North America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. North America Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 109. North America Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 110. North America Efavirenz Tablets Sales Forecast by Country (2027-2032) & (k units) Table 111. North America Efavirenz Tablets Sales Market Share Forecast by Country (2027-2032) Table 112. North America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Efavirenz Tablets Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Efavirenz Tablets Market Share by Country (2021-2026) Table 115. North America Efavirenz Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Efavirenz Tablets Market Share Forecast by Country (2027-2032) Table 117. Europe Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Europe Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 119. Europe Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 120. Europe Efavirenz Tablets Sales Forecast by Country (2027-2032) & (k units) Table 121. Europe Efavirenz Tablets Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Efavirenz Tablets Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Efavirenz Tablets Market Share by Country (2021-2026) Table 125. Europe Efavirenz Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Efavirenz Tablets Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 129. Asia-Pacific Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Efavirenz Tablets Sales Forecast by Country (2027-2032) & (k units) Table 131. Asia-Pacific Efavirenz Tablets Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Efavirenz Tablets Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Efavirenz Tablets Market Share by Country (2021-2026) Table 135. Asia-Pacific Efavirenz Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Efavirenz Tablets Market Share Forecast by Country (2027-2032) Table 137. Latin America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Latin America Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 139. Latin America Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 140. Latin America Efavirenz Tablets Sales Forecast by Country (2027-2032) & (k units) Table 141. Latin America Efavirenz Tablets Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Efavirenz Tablets Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Efavirenz Tablets Market Share by Country (2021-2026) Table 145. Latin America Efavirenz Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Efavirenz Tablets Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Efavirenz Tablets Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Efavirenz Tablets Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Efavirenz Tablets Sales Forecast by Country (2027-2032) & (k units) Table 151. Middle East and Africa Efavirenz Tablets Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Efavirenz Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Efavirenz Tablets Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Efavirenz Tablets Market Share by Country (2021-2026) Table 155. Middle East and Africa Efavirenz Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Efavirenz Tablets Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Efavirenz Tablets Distributors List Table 160. Efavirenz Tablets Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Efavirenz Tablets Image Figure 2. Global Efavirenz Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Efavirenz Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Efavirenz Tablets Sales (2021-2032) & (k units) Figure 5. 200mg Image Figure 6. Global 200mg Sales YoY Growth (2021-2032) & (k units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (k units) Figure 9. 600mg Image Figure 10. Global 600mg Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Efavirenz Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Efavirenz Tablets Market Share by Type 2025 VS 2032 Figure 13. North America Efavirenz Tablets Sales Market Share in Volume by Type in 2025 Figure 14. North America Efavirenz Tablets Sales Market Share in Value by Type in 2025 Figure 15. Europe Efavirenz Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Efavirenz Tablets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Efavirenz Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Efavirenz Tablets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Efavirenz Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Efavirenz Tablets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Efavirenz Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Efavirenz Tablets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Efavirenz Tablets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 27. Child Image Figure 28. Global Child Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Efavirenz Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Efavirenz Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Efavirenz Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Efavirenz Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Efavirenz Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Efavirenz Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Efavirenz Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Efavirenz Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Efavirenz Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Efavirenz Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Efavirenz Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Efavirenz Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Efavirenz Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Efavirenz Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Efavirenz Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Efavirenz Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Efavirenz Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Efavirenz Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Efavirenz Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Efavirenz Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Efavirenz Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Efavirenz Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Efavirenz Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Efavirenz Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Efavirenz Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Efavirenz Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 50mg
  • 600mg
Applications
  • Adult
  • Child
Companies covered
  • Aurobindo Pharma
  • Cipla
  • Hetero
  • Strides Pharma
  • Anhui Biochem Bio-Pharmaceutical
  • Huahai Pharmaceutical
  • DESANO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Efavirenz Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Efavirenz Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Efavirenz Tablets Market by Type
  6. 1.3.1 200mg
  7. 1.3.2 50mg
  8. 1.3.3 600mg
  9. 1.4 Global Efavirenz Tablets Market Size by Type
  10. 1.4.1 Global Efavirenz Tablets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Efavirenz Tablets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Efavirenz Tablets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Efavirenz Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Efavirenz Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Efavirenz Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Efavirenz Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Efavirenz Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Efavirenz Tablets Industry Trends
  2. 2.2 Efavirenz Tablets Industry Drivers
  3. 2.3 Efavirenz Tablets Industry Opportunities and Challenges
  4. 2.4 Efavirenz Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Efavirenz Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Efavirenz Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Efavirenz Tablets Price (2021-2026)
  4. 3.4 Global Efavirenz Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Efavirenz Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Efavirenz Tablets Company, Product Type & Application
  7. 3.7 Global Efavirenz Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Efavirenz Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Efavirenz Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Efavirenz Tablets Tier 1, Tier 2, and Tier 3
4 Efavirenz Tablets Regional Status and Outlook
  1. 4.1 Global Efavirenz Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Efavirenz Tablets Historic Market Size by Region
  3. 4.2.1 Global Efavirenz Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Efavirenz Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Efavirenz Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Efavirenz Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Efavirenz Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Efavirenz Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Efavirenz Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Efavirenz Tablets by Application
  1. 5.1 Efavirenz Tablets Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Child
  4. 5.2 Global Efavirenz Tablets Market Size by Application
  5. 5.2.1 Global Efavirenz Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Efavirenz Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Efavirenz Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Efavirenz Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Efavirenz Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Efavirenz Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Efavirenz Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Efavirenz Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurobindo Pharma Efavirenz Tablets Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Efavirenz Tablets Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Hetero
  14. 6.3.1 Hetero Company Information
  15. 6.3.2 Hetero Business Overview
  16. 6.3.3 Hetero Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hetero Efavirenz Tablets Product Portfolio
  18. 6.3.5 Hetero Recent Developments
  19. 6.4 Strides Pharma
  20. 6.4.1 Strides Pharma Company Information
  21. 6.4.2 Strides Pharma Business Overview
  22. 6.4.3 Strides Pharma Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Strides Pharma Efavirenz Tablets Product Portfolio
  24. 6.4.5 Strides Pharma Recent Developments
  25. 6.5 Anhui Biochem Bio-Pharmaceutical
  26. 6.5.1 Anhui Biochem Bio-Pharmaceutical Company Information
  27. 6.5.2 Anhui Biochem Bio-Pharmaceutical Business Overview
  28. 6.5.3 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Anhui Biochem Bio-Pharmaceutical Efavirenz Tablets Product Portfolio
  30. 6.5.5 Anhui Biochem Bio-Pharmaceutical Recent Developments
  31. 6.6 Huahai Pharmaceutical
  32. 6.6.1 Huahai Pharmaceutical Company Information
  33. 6.6.2 Huahai Pharmaceutical Business Overview
  34. 6.6.3 Huahai Pharmaceutical Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huahai Pharmaceutical Efavirenz Tablets Product Portfolio
  36. 6.6.5 Huahai Pharmaceutical Recent Developments
  37. 6.7 DESANO
  38. 6.7.1 DESANO Company Information
  39. 6.7.2 DESANO Business Overview
  40. 6.7.3 DESANO Efavirenz Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 DESANO Efavirenz Tablets Product Portfolio
  42. 6.7.5 DESANO Recent Developments
7 North America by Country
  1. 7.1 North America Efavirenz Tablets Sales by Country
  2. 7.1.1 North America Efavirenz Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Efavirenz Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Efavirenz Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Efavirenz Tablets Market Size by Country
  6. 7.2.1 North America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Efavirenz Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Efavirenz Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Efavirenz Tablets Sales by Country
  2. 8.1.1 Europe Efavirenz Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Efavirenz Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Efavirenz Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Efavirenz Tablets Market Size by Country
  6. 8.2.1 Europe Efavirenz Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Efavirenz Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Efavirenz Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Efavirenz Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Efavirenz Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Efavirenz Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Efavirenz Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Efavirenz Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Efavirenz Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Efavirenz Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Efavirenz Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Efavirenz Tablets Sales by Country
  2. 10.1.1 South America Efavirenz Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Efavirenz Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Efavirenz Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Efavirenz Tablets Market Size by Country
  6. 10.2.1 South America Efavirenz Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Efavirenz Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Efavirenz Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Efavirenz Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Efavirenz Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Efavirenz Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Efavirenz Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Efavirenz Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Efavirenz Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Efavirenz Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Efavirenz Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Efavirenz Tablets Value Chain Analysis
  2. 12.1.1 Efavirenz Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Efavirenz Tablets Production Mode & Process
  7. 12.2 Efavirenz Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Efavirenz Tablets Distributors
  10. 12.2.3 Efavirenz Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst